Details of the Drug Formulations

General Information of Drug (ID: DMKV4NL)

Drug Name
Flavoxate Drug Info
Synonyms
Bladuril; Flavossato; Flavoxato; Flavoxatum; Urispas; Flavossato [DCIT]; Flavoxate HCI; Flavoxate HCL; Spasuret hydrochloride; AK 123; Bladderon (TN); Bladuril (TN); DW-61; Flavoxate (INN); Flavoxate [INN:BAN]; Flavoxato [INN-Spanish]; Flavoxatum [INN-Latin]; Urispas (TN); Uritac (TN); Zopyran-8-carboxylate; Beta-piperidinoethyl 3-methylflavone-8-carboxylate; Piperidinoethyl-3-methylflavone-8-carboxylate; 1-Piperidinoethanol, 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate; 2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate; 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate; 2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylat; 2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate; 2-Piperidinoethyl-3-methyl-4-oxo-2-phenyl-4H-1-ben; 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate; 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate; 2-piperidinoethyl 3-methylflavone-8-carboxylate; 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester
Indication
Disease Entry ICD 11 Status REF
Dysuria MF50.7 Approved [1]
Nocturia MF55 Approved [1]
Suprapubic pain MG30-MG3Z Approved [1]
Urgency N.A. Approved [1]
Priapism Investigative [2]
Therapeutic Class
Parasympatholytics
Cross-matching ID
PubChem CID
3354
ChEBI ID
CHEBI:5088
CAS Number
15301-69-6
TTD ID
D0ND2J
VARIDT ID
DR00726
ACDINA ID
D00277

Full List of Drug Formulations Containing This Drug

Flavoxate 100 mg tablet
Company Formulation ID FDA Description
Carilion Materials Management; Paddock Laboratories, F08264 Lactose monohydrate; Ethyl acrylate; Magnesium stearate; Methyl methacrylate; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2910 (6 mpa.s); Hypromelloses; Nonoxynol-100; Polyethylene glycols; Sodium starch glycolate type a potato
AvPAK; Golden State Medical Supply F08263 Magnesium stearate; Dibasic calcium phosphate dihydrate; Titanium dioxide; Triacetin; Silicon dioxide; Hypromellose phthalate (24% phthalate, 55 cst); Polydextrose; Starch, corn
Epic Pharma; PuraCap Laboratories F08265 Magnesium stearate; Calcium phosphate, dibasic, dihydrate; Titanium dioxide; Triacetin; Silicon dioxide; Hypromellose 2910 (50 mpa.s); Polydextrose; Polyethylene glycol 8000; Starch, corn
Physicians Total Care; TAGI Pharma F08266 Magnesium stearate; Dibasic calcium phosphate dihydrate; Titanium dioxide; Triacetin; Silicon dioxide; Hypromelloses; Polydextrose; Starch, corn
Global Pharmaceuticals F08262 Magnesium stearate; Dibasic calcium phosphate dihydrate; Polyethylene glycol 400; Cellacefate; Hypromellose 2910 (6 cps); Starch, corn
------------------------------------------------------------------------------------
Flavoxate Hydrochloride 100mg tablet
Company Formulation ID FDA Description
Epic Pharma F23332 Silicon Dioxide; Starch, Corn; Calcium Phosphate, Dibasic, Dihydrate; Magnesium Stearate; Hypromellose 2910; Polydextrose; Polyethylene Glycol 8000; Titanium Dioxide; Triacetin
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Flavoxate FDA Label